| Financial Year |
March 31 2023 |
| Monetary Funds |
575,515,646.14 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
75,822,339.86 |
| Accounts Receivable |
889,446,591.84 |
| Advances to Suppliers |
401,197,997.94 |
| Other Receivables |
32,184,700.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,310,865,572.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,415.10 |
| Total Current Assets |
3,607,828,317.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
861,815,721.32 |
| Under-construction Projects |
14,602,207.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
142,586,968.93 |
| R&D expenses |
-- |
| Goodwill |
2,601,641.09 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
34,411,315.04 |
| Other Non-Current Assets |
31,960,078.96 |
| Sub-Total of Non-Current Assets |
1,104,088,939.38 |
| Total Assets |
4,711,917,256.56 |
| Short-Term Loans |
612,404,781.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
165,176,180.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,416,397.31 |
| Taxes Payable |
21,635,192.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,343,569.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,376,682.31 |
| Other Current Liabilities |
35,091,745.60 |
| Sub-Total of Current Liabilities |
1,166,381,053.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
168,887,865.34 |
| Total Liabilities |
1,335,268,919.11 |
| Paid-In Capital(Or Share Stock) |
520,535,520.00 |
| Capital Surplus |
773,658,121.18 |
| Surplus Reserve |
202,452,563.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,663,601,857.32 |
| Minority Stockholder's Interest |
216,400,275.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,160,248,062.33 |
| Owner's Equity（Stockholder's Equity） |
3,376,648,337.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,711,917,256.56 |
